A non-synonymous single nucleotide polymorphism of the human serotonin 5-HT 2C receptor (5-HT 2C R) gene that converts a cysteine to a serine at amino acid codon 23 (Cys23Ser) appears to impact 5-HT 2C R pharmacology at a cellular and systems level. We hypothesized that the Cys23Ser alters 5-HT 2C R intracellular signaling via changes in subcellular localization in vitro. Using cell lines stably expressing the wild-type Cys23 or the Ser23 variant, we show that 5-HT evokes intracellular calcium release with decreased potency and peak response in the Ser23 versus the Cys23 cell lines. Biochemical analyses demonstrated lower Ser23 5-HT 2C R plasma membrane localization versus the Cys23 5-HT 2C R. Subcellular localization studies demonstrated O-linked glycosylation of the Ser23 variant, but not the wild-type Cys23, may be a post-translational mechanism which alters its localization within the Golgi apparatus. Further, both the Cys23 and Ser23 5-HT 2C R are present in the recycling pathway with the Ser23 variant having decreased colocalization with the early endosome versus the Cys23 allele. Agonism of the 5-HT 2C R causes the Ser23 variant to exit the recycling pathway with no effect on the Cys23 allele. Taken together, the Ser23 variant exhibits a distinct pharmacological and subcellular localization profile versus the wild-type Cys23 allele, which could impact aspects of receptor pharmacology in individuals expressing the Cys23Ser SNP.
Results
The Cys23Ser SNP alters the functional response of the 5-HT 2C R to 5-HT. Most signaling studies focused on GPCRs utilize immortal mammalian cell lines as these are easily manipulated, allow for better control of expression levels of the gene of interest, and are straightforwardly amenable to bioresponsive and subcellular localization assays. We employed RNAseq analyses to demonstrate that CHO cell lines express some of the major players in 5-HT 2C R localization and signaling, including Camk1 (Calmodulin) 38, 39 , Pten (PTEN, phosphatase and tensin homolog) 40, 41 , and low levels of Dlg4 (PSD95, postsynaptic density 95) 32 (unpublished observations). We engineered CHOp38 cells 42 (CHO cells expressing synaptophysin/p38, see Methods for details on the generation of the cell line) to stably express the human Cys23 allele or the Ser23 allele of the non-edited (INI) 5-HT 2C R. During the generation of our stable cell lines we were able to select for 35 Cys23-expressing clones and one Ser23expressing clone. Each clone was evaluated for total 5-HT 2C R protein expression using the Wes TM automated Western blotting system. Three Cys23 5-HT 2C R CHOp38 clones were selected: one with equal 5-HT 2C R expression (Cys23 Clone 1) to the Ser23 5-HT 2C R CHOp38 cell line, one with 5-HT 2C R expression greater than Cys23 Clone 1 (Cys23 Clone 2) and one with 5-HT 2C R expression lower than Cys23 Clone 1 (Cys23 Clone 3). As shown in Supplementary Fig. 1 , there was a concentration-dependent increase in ++ Ca i levels following 5-HT administration in all four clones. The 5-HT peak response for the Ser23 (E max = 57.62 ± 14.83%) was ~43% lower relative to Cys23 Clone 1 (E max = 101.4 ± 19.16%). The Cys23 Clone 2 had a 36.4% higher 5-HT peak response (E max = 137.8 ± 19.95%) while Cys23 Clone 3 demonstrated a 9.46% decrease in 5-HT peak response (E max = 91.94 ± 4.56%) versus Cys23 Clone 1. The chosen Cys23 (Clone 1) and Ser23 lines with equal levels of total 5-HT 2C R protein were employed for all additional analyses presented herein.
To test the hypothesis that the Cys23Ser SNP alters 5-HT 2C R-mediated signaling release relative to the wild-type 5-HT 2C R, we assessed ++ Ca i release 40 . As shown in Fig. 1 , there was a concentration-dependent increase in ++ Ca i levels following 5-HT administration in both the Cys23 5-HT 2C R-CHOp38 and Ser23 5-HT 2C R-CHOp38 cells. The Ser23 allele-expressing cells ( Fig. 1 , pEC 50 = 8.54 ± 0.22) displayed a lower potency versus the Cys23 allele-expressing cells ( Fig. 1 , pEC 50 = 9.24 ± 0.17; t(9) = 2.56, p < 0.05). These data are consistent with previous reports showing a shift in the potency of the Ser23 allele relative to the Cys23 allele 27, 29, 43 . The 5-HT peak response in the Ser23 allele-expressing cells ( Fig. 1 ; E max = 57.62 ± 6.63%) was ~43% lower relative to the Cys23 allele-expressing cells ( Fig. 1 ; E max = 101.4 ± 7.82%; t(9) = 4.16, p < 0.05). As expression of the Ser23 allele results in the loss of the single cysteine residue in the N-terminus, the removal of the Cys-dependent disulfide bond formation may alter the conformation of the 5-HT 2C R and ultimately impact the potency of 5-HT to activate the Ser23 variant 43, 44 .
This pharmacological profile was observed despite the fact that total 5-HT 2C R protein expression between the Cys23 allele-and Ser23 allele-expressing cells was comparable ( Fig. 2A ). Saturation radioligand binding assays revealed that the Cys23 and Ser23 5-HT 2C R-CHO-p38 cell lines stably express similar levels of 5-HT 2C R (B MAX = 49.4 ± 13.8 and 69.9 ± 10.5 fmol/mg protein, for the Cys23 and Ser23 5-HT 2C R-CHO-p38 respectively; n.s.) ( Fig. 2A) . Additionally, both cell lines exhibited similar affinity (K D ) for [ 3 H]-mesulergine of 2.58 ± 0.47 and 2.90 ± 0.40 nM for the Cys23 and Ser23 5-HT 2C R-CHO-p38 cell lines, respectively (n.s.) ( Fig. 2A ). Total protein expression of the 5-HT 2C R as assessed using the Wes TM automated Western blotting system showed no significant difference between the Cys23 and Ser23 5-HT 2C R-CHOp38 cells ( Fig. 2B and Supplementary Fig. 2A ; n.s.). Stable transfection of the Cys23 allele or Ser23 allele into the CHOp38 cells did not alter total transferrin receptor (TfR) ( Fig. 2C and Supplementary Fig. 2C , n.s.) or synaptophysin/p38 ( Fig. 2D and Supplementary Fig. 2D , n.s.) protein expression levels. We propose that the lower maximal 5-HT-induced Ca i ++ response by the Ser23 variant may be due to differences in plasma membrane localization of the 5-HT 2C R as the subcellular localization can fundamentally control the signaling efficacy and specificity of GPCRs.
Cys23Ser SNP lowers 5-HT 2C R plasma membrane localization. Extracellular N-terminus SNPs
within class A GPCRs are reported to demonstrate lower surface expression, alter constitutive activity and half-life of the receptor 45, 46 . To test the hypothesis that the Cys23Ser SNP impacts 5-HT 2C R plasma membrane localization, dual-labeled immunocytochemistry was used to detect colocalization of the 5-HT 2C R with the plasma membrane marker wheat germ agglutinin (WGA) in cells expressing the Cys23 allele or Ser23 allele. Representative confocal series photomicrographs of the 5-HT 2C R and WGA staining for the Cys23 allele ( Fig. 3A ) and the Ser23 allele ( Fig. 3B ) are provided. In the Cys23 allele-expressing cells, the 5-HT 2C R ( Fig. 3A ; green) localized to a greater extent at the plasma membrane ( Fig. 3A ; red) as emphasized by the orthogonal views of the xz and yz axis demonstrating the colocalization ( Fig. 3A ; yellow) of the 5-HT 2C R and WGA at the plasma membrane. In the Ser23 allele-expressing cells, the 5-HT 2C R ( Fig. 3B ; green) demonstrates very little colocalization with WGA ( Fig. 3B ; red) evidenced by a diminished pattern of the 5-HT 2C R and WGA colocalization ( Fig. 3B ; yellow) at the plasma membrane. Quantification of colocalization for the 5-HT 2C R with WGA in the Cys23 allele-and Ser23 allele-expressing cells was performed on single mid-cell confocal images 47, 48 and are represented as a Pearson's correlation 49 (Fig. 3C ). The Cys23 allele-expressing cells had significantly higher colocalization with WGA versus the Ser23 allele-expressing cells ( Figure 3B ; yellow) are provided. Scatter plots demonstrating the level of 5-HT 2C R (green pixel intensity), WGA (red pixel intensity), and colocalization (yellow pixel intensity) demonstrate less colocalization between Ser23 allele-expressing cells and WGA relative to Cys23 allele-expressing cells and WGA (Supplementary Figure 3A,B) .
The different profile of plasma membrane levels between the Cys23 allele-and Ser23 allele-expressing cells was next assessed using the Wes TM automated Western blotting system 13, 50 of plasma membrane-enriched protein fractions 13, 14, 51, 52 isolated from the Cys23 5-HT 2C R-CHOp38 cells or Ser23 5-HT 2C R-CHOp38 cells. Levels of 5-HT 2C R plasma membrane-enriched protein expression were lower in cells expressing the Ser23 allele versus the Cys23 allele ( Fig. 3D and Supplementary Fig. 2B , t(12) = 2.01, p < 0.05). Levels of 5-HT 2C R in the cytoplasmic protein fraction were not significantly different between the Cys23 allele-(0.826 ± 0.15 A.U.) and Ser23 allele-expressing cells (0.72 ± 0.03 A.U., n.s.). Surface biotinylation studies followed by Western blot analysis showed surface 5-HT 2C R protein expression was less in cells stably expressing the Ser23 versus the Cys23 allele ( Supplementary Fig. 4) . No difference in non-surface 5-HT 2C R expression or total 5-HT 2C R expression was detected between Cys23 and Ser23 5-HT 2C R-CHOp38 cells. Thus, the Ser23 variant directly influences the localization of the 5-HT 2C R at the plasma membrane versus the wild-type Cys23.
Inhibition of O-linked glycosylation reduces colocalization of the Ser23 variant with the Golgi apparatus.
Single nucleotide polymorphisms in the N-terminus of GPCRs alter the pattern of glycosylation, a We next investigated colocalization of the 5-HT 2C R variants within the Golgi apparatus due to the presence of GalNac transferase and O-glycosylation in the Golgi apparatus [54] [55] [56] [57] [58] [59] and the knowledge that O-glycosylation impacts protein folding and structure (for review 60 ) as well as possibly localization and targeting of proteins [61] [62] [63] to support the hypothesis that O-glycosylation could be a part of protein quality control for the 5-HT 2C R and, thus, impacted by the Cys23Ser SNP. We tested this hypothesis by incubating Cys23 or Ser23 5-HT 2C R expressing cells with 2 mM Benzyl 2-acetamido-2-deoxy-α-D-galactopyranoside (GalNac-O-Bn), a broad range competitive GalNac transferase inhibitor 61, 62, [64] [65] [66] , and then analyzed 5-HT 2C R colocalization with the cis-Golgi apparatus marker GRASP65 (Golgi reassembly-stacking protein of 65 kDa) 67 . Representative single mid-cell photomicrographs of the 5-HT 2C R in the Cys23 allele-expressing cells ( Fig. 4A ; green), GRASP65 ( Fig. 4A ; red) and colocalization of the 5-HT 2C R with GRASP65 ( Fig through the receptor recycling pathways; this process also controls the availability of the cell surface 5-HT 2C R to bind ligands and initiate downstream intracellular signaling [35] [36] [37] . The actual impact of the Cys23Ser SNP on 5-HT 2C R localization through the recycling pathway is not known. Our CHOp38 cells stably express synaptophysin/p38 and transferrin receptor (TfR) 42 . The TfR undergoes recycling constitutively, in the presence or absence of transferrin (Tfn) binding, and is a useful way to track the bulk plasma membrane traversing the receptor recycling pathway 68 . Further, synaptophysin/p38 colocalizes with internalized Tfn and the TfR on early endosomes 42, 69 . Thus, TfR localization can be used as a marker for the recycling pathway in CHOp38 cells. 
Serotonin treatment differentially alters the Cys23 versus Ser23 5-HT 2C R localization within early endosomes.
As the TfR is localized to multiple compartments within the recycling pathway, including the plasma membrane, early and recycling endosomes 69, 70 , we wanted to further delineate the profile of the www.nature.com/scientificreports www.nature.com/scientificreports/ Quantification of colocalization (yellow pixel intensity) for the 5-HT 2C R with EEA1 in the Cys23 allele-and Ser23 allele-expressing cells was performed on single mid-cell confocal images 47, 48 and represented as a Pearson's correlation 49 . A two-way ANOVA comparing 5-HT treatment and the different 5-HT 2C R alleles revealed a significant genotype effect only (F(1, 8) = 7.26, p < 0.05), indicating that genotype had a similar effect on treatment status. Subsequent analysis of Ser23 allele-expressing cells demonstrated significantly less colocalization with EEA1 than the Cys23 allele-expressing cells (Fig. 6 , t(4) = 2.916, p < 0.05) basally. Serotonin treatment of the Cys23 allele-expressing cells induced a trend towards a decrease in the colocalization of Cys23 5-HT 2C R with EEA1 ( Fig. 6C , t(4) = 1.869, p = 0.067) with no effect on Ser23 5-HT 2C R colocalization with EEA1 ( Fig. 6D ; n.s.). While both the wild-type Cys23 and the Ser23 variant are capable of early endosome internalization, the Ser23 variant is found to a lower degree even after agonist stimulation (Fig. 6D ), possibly as a result of less plasma membrane 5-HT 2C R available for endocytosis.
Discussion
We discovered that the Ser23 variant demonstrated lower maximum 5-HT-induced ++ Ca i release and a decreased potency versus the wild-type Cys23. Western blot and immunocytochemistry results indicated lower 5-HT 2C R plasma membrane localization in the Ser23 allele-versus the Cys23 allele-expressing cell lines, with total protein levels equal. Further, O-linked glycosylation of the Ser23 variant, but not the wild-type Cys23, may be a post-translational mechanism which alters its localization within the Golgi apparatus and subsequent localization to the plasma membrane. Subcellular localization studies detected no differences between the Cys23 and Ser23 co-localization with TfR under basal conditions, while less co-localization with EEA1 was observed for the Ser23 versus the Cys23 under basal conditions. Further, the Cys23 allele potentially has lower agonist-induced EEA1 localization but does not exit the recycling pathway as evidenced by no change in colocalization with the TfR. In contrast, the Ser23 variant leaves the recycling pathway (i.e., less agonist-induced TfR colocalization), but there was no agonist-induced effect on EEA1 colocalization. These data suggest that the Cys23 allele has the potential to be recycled and that lower levels of basal plasma membrane expression of the Ser23 variant may indicate less available receptor at the plasma membrane to be internalized after agonist stimulation. Taken together, the Ser23 www.nature.com/scientificreports www.nature.com/scientificreports/ variant exhibits a distinct pharmacological and subcellular localization profile versus the wild-type Cys23 allele, which could impact aspects of receptor pharmacology in individuals expressing the Cys23Ser SNP.
The ultimate level of functional activity of the 5-HT 2C R is determined by a culmination of factors, including the number and availability of active pools of receptors at the plasma membrane and effective coupling to and activation of downstream signaling components. Our findings demonstrate that the naturally occurring Ser23 variant imparts profoundly reduced calcium signaling activity (potency and efficacy) as well as lower plasma membrane localization. Studies investigating the impact of the Cys23Ser SNP on 5-HT 2C R function are few and far between with relatively contradictory results. A decrease in potency, but not efficacy, in the Ca i ++ release assay for cells expressing the Ser23 variant versus the wild-type Cys23 was reported 27 . Intriguingly, signaling through IP 3 formation is identical between the variants 28 . Transient overexpression of the Ser23 produces higher constitutive activity, agonist-induced desensitization, and differential resensitization time courses and plasma membrane localization patterns 27 , which likely contributes to the observed altered pharmacological responsiveness 29 . Further, the Ser23 variant resensitizes more rapidly following prolonged inverse agonist exposure relative to the wild-type Cys23 29 , possibly due to differences in recovery from constitutive internalization 35, 71 . Rapid transmembrane signaling events require cell surface binding of 5-HT to the 5-HT 2C R to facilitate Gα q/11 coupling and the activation of plasma membrane located PLCβ to generate intracellular second messengers IP 3 and Ca i ++ release 2 . As ligand-mediated G protein-dependent downstream cascades converge to stimulate Ca i ++ release, it is conceivable that the multiple agonist-directed signaling pathways are differentially recruited by the Ser23 variant, as opposed to the wild-type Cys23, suggesting that the discrepancies in the literature may be due to the signaling endpoint analyzed. Further, our discovery of lower plasma membrane targeting for the Ser23 likely also contributes to the deficient calcium signaling observed.
The 5-HT 2C R contains a 57 amino acid N-terminus tail with two predicted cleavage sites after amino acid 32 or 22 72, 73 . Cleavage of the signal peptide is an essential step for the processing of the GPCR from the ER to the Golgi apparatus and ultimately to the plasma membrane; malfunction of this process can result in the intracellular retention of the 5-HT 2C R during maturation 72, 73 . If cleavage of the signal peptide occurs at amino acid 32, the maturation of the 5-HT 2C R (independent of the allele expressed) as well as subsequent proper targeting to the www.nature.com/scientificreports www.nature.com/scientificreports/ plasma membrane could be impacted 72, 73 . Alternatively, if cleavage at amino acid 22 occurs 72,73 , then the presence of the Ser23 allele and removal of the Cys-dependent disulfide bond in the mature 5-HT 2C R would have a greater impact on the efficacy of cleavage, maturation, and targeting to the plasma membrane. This is a unique property of the 5-HT 2C R and warrants future investigation as to the effect on ligand-mediated functional capacity and/or constitutive activity.
The clinical implications of the Cys23Ser SNP suggest an association between expression of the Ser23 variant and phenotypic behaviors. Specifically, subjects who carry the Ser23 exhibit greater dopamine release in striatal regions in response to salient, stressful stimuli 21 ; the 5-HT 2C R regulates dopamine release in the meso-corticoaccumbens circuit, specifically, agonists decrease dopamine release while antagonists increase dopamine release [74] [75] [76] . Cocaine-dependent subjects expressing the Ser23 variant have higher cue reactivity as compared to subjects expressing the wild-type Cys23 24 ; reduced plasma membrane localization and pharmacological responsiveness of the 5-HT 2C R corresponds to higher cue reactivity in preclinical studies [11] [12] [13] . We discovered that the plasma membrane localization of the Ser23 variant is less and has an altered distribution in the recycling pathway compared to the wild-type Cys23. Our results in stable-expressing cell lines and previous reports using radioligand binding of transiently transfected cells 27, 28 demonstrate similar levels for these two receptor variants (but see 29 ) , indicating reduced functional activity of the Ser23 is not due to reduced total receptor levels. Taken together, these results may elucidate a potential neurobiological mechanism whereby the Cys23Ser SNP influences the subcellular localization and signaling capacity in the human participants; however, this is unknown at this time. As the functional capacity of the 5-HT 2C R is most likely brain region dependent and highly responsive in the brain, more detailed in vitro studies which investigate differences in pharmacological responsiveness (e.g., constitutive activity, ligand-mediated signaling, desensitization/resensitization processes) are critical not only because of phenotype linkage, but also medication responsiveness in humans.
In summary, the Cys23Ser SNP alters the subcellular localization and ultimately function of the 5-HT 2C R (Fig. 7) . Changes in the function and localization of the 5-HT 2C R have strong implications for the use of 5-HT 2C R ligands in individuals that express the Cys23Ser SNP and we propose future studies in which the function and localization of the Cys23Ser SNP is investigated in the native neuronal environment are warranted. Taken together, a greater appreciation of the full spectrum of genetic mutations and subsequent downstream signal www.nature.com/scientificreports www.nature.com/scientificreports/ activation is critical when elucidating the functional status of these receptors in neural mechanisms, including the various regulatory features (e.g., subcellular localization) that serve to modulate downstream activation and functionally distinguish 5-HT 2C R variants actions.
Methods
Ligands. Serotonin (5-HT, Acros Organics, Thermo Fisher Scientific, Fair Lawn, NY) was dissolved in 1x HBSS (Cellgro; Invitrogen, Manassas, VA). Benzyl 2-acetamido-2-deoxy-α-D-galactopyranoside (GalNac-O-Bn, Sigma-Aldrich, St. Louis, MO) was dissolved in serum free Dulbecco's modified Eagle's medium. All purchased compounds for the radioligand binding assay were >98% pure according to the manufacturers. Mianserin hydrochloride (Sigma Aldrich, St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO) (10 mM) and prepared fresh daily. Intracellular calcium release assay. The intracellular calcium ( ++ Ca i ) release assay was performed as previously described with minor modifications 40 . Briefly, 150 µL of cells from passages 8-12 were plated in black wall, flat, clear bottom 96-well tissue culture plates at a density of 16,000 cells/well in normal growth media. Care was taken to ensure even plating of cells, including frequent agitation or trituration of cells in the source reservoir; plates were placed on a rotary shaker at low speed for 10 min at room temperature. Approximately 24 hr following plating, the normal growth media was removed, and cells were fed with serum-free (SF) Dulbecco's modified Eagle's medium. Following a 3-hr incubation at 37 °C, SF medium was replaced with 40 µL Hank's balanced saline solution (HBSS; without CaCl 2 or MgCl 2 , pH 7.4) plus 40 µL Calcium 4 dye solution (FLIPR No-wash kit R8142, Molecular Devices, Sunnyvale, CA) supplemented with 2.5 mM of water-soluble probenicid (Sigma, St. Louis, MO) to inhibit extracellular transport of the dye. Plates were incubated for 60 min at 37 °C followed by 30 min at 25 °C in the dark.
Calcium-induced fluorescence signal (ex = 485 nm, em = 525 nm) was measured with a FlexStation 3 instrument (Molecular Devices). A baseline was established for each well during the initial component of each run. Addition of 20 µL of 5X concentrated 5-HT or vehicle (HBSS) occurred at 17 sec, and fluorescence was recorded every 1.7 sec for 60 sec to determine agonist activity. Maximum peak heights were determined by the SoftMax software (Pro 5.4.5; Molecular Devices) for each well. After the final readings, cells were fixed in 2% paraformaldehyde (Sigma) for 45 min at room temperature. After fixation, cells were rinsed with water, air dried, and 50 µL of filtered crystal violet solution (0.1% in water) was added for 10 min at 25 °C, and the wells were rinsed again. Absorbance in 50 µL of 10% acetic acid was read at 590 nm. Peak ++ Ca i release responses from each well were normalized to total cell mass as determined with crystal violet staining, a value proportional to cell mass that can be used as an estimate of cell number 40 . The responses were then normalized to the average 1 µM 5-HT response in the Cys23 5-HT 2C R-CHOp38 (Clone 1) to give a percent response. Each experiment was performed in technical triplicates with two to six biological replicates.
Saturation binding assay.
Stably transfected Cys23 5-HT 2C R-CHOp38 and Ser23 5-HT 2C R-CHO-p38 cells were scraped from plates and collected by centrifugation at 4000 g at 4 °C for 25 mins in ice cold assay buffer containing 50 mM Tris HCl, 10 mM MgCl 2 and 0.1 mM EDTA. Samples were collected by centrifugation three times at 4500 g at 4 °C for 20 mins and were used fresh for binding assays. Saturation binding isotherms were performed in 96-well plates using similar methods as previously reported 77 . For saturation binding assays, 0.02 to 15 nM of [ 3 H]-mesulergine (PerkinElmer, Waltham, MA) was used to obtain affinity (K D ) and receptor concentration (B MAX ) values. Non-specific binding was determined in the presence of 10 µM of mianserin hydrochloride (Sigma Aldrich, St. Louis MO). The reaction mixtures were incubated at 25 °C for 90 mins on a plate shaker in the dark to reach equilibrium, and then passed rapidly through a printed filtermat soaked in 0.5% polyethylenimine using a FilterMate Harvester (PerkinElmer, Waltham, MA). The printed filtermat containing bound [ 3 H]-mesulergine was microwaved for one minute to dry, then a MeltiLex sheet was melted onto the printed filtermat via a hotplate. The contents were sealed and counted for scintillation using a MicroBeta 2 (PerkinElmer, Waltham, MA). Direct radioligand concentrations were measured by pipetting into 1 mL of Optiphase Supramix (PerkinElmer, Waltham, MA) and measured on a Tri-Carb 2910TR liquid scintillation analyzer (PerkinElmer, Waltham, MA). Protein concentrations were determined using the bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Waltham, MA) by measuring absorbance values (562 nm) on a H4 synergy reader (Biotek, Winooski, VT). Each experiment was performed in technical triplicates with three biological replicates.
Protein extraction and immunoblotting. Plasma membrane-enriched and cytoplasmic protein fractions were prepared via differential centrifugation as previously described with minor modifications 13, 50 . This well-established differential centrifugation method enriches for the plasma membrane and will also contain membranes from other organelles such as the ER and Golgi apparatus. However, this fraction still contains a majority www.nature.com/scientificreports www.nature.com/scientificreports/ of plasma membrane and has been used numerous times to show changes in plasma membrane expression of proteins 13, 14, 51, 52 . Cells (~3-7 × 10 7 ) were homogenized in 300-600 µL of extraction buffer [(10 mM HEPES, 1 mM EDTA, 2 mM EGTA, 1 mM dithiothreitol (DTT), 10 mM MgCl 2 ), plus protease inhibitor cocktail and phosphatase inhibitor 2 and 3 cocktails (10 µL/mL; Sigma-Aldrich, St. Louis, MO)]. The homogenate was centrifuged at 1,000 g for 10 min at 4 °C to pellet the nuclear fraction. The supernatant (S1) was collected and an aliquot was saved as the total homogenate (TH) fraction, the remaining TH fraction was centrifuged at 15,000 g for 30 min at 4 °C to pellet the plasma membrane-bound enriched protein fraction (P2). The supernatant (S2) was collected and centrifuged at 20,000 g for 80 min at 4 °C to pellet the plasma membrane-bound enriched protein fraction (P3). The plasma membrane-enriched pellets were resuspended in buffer [20 mM HEPES, 200 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 10 mM MgCl 2 , protease inhibitor cocktail and phosphatase inhibitor 2 and 3 cocktails (10 µL/mL)] plus 1% NP40. The two plasma membrane-bound enriched protein fractions were combined to give the crude plasma membrane fraction. The cytoplasmic fraction was collected and reserved. All protein fractions were stored at −20 °C until use.
For the subcellular localization studies, plasma membrane-enriched, cytoplasmic and total homogenate fractions were assessed using the Wes TM automated Western blotting system (ProteinSimple, San Jose, CA) according to the manufacturers specifications. Wes TM reagents (biotinylated molecular weight marker, streptavidin-HRP fluorescent standards, luminol-S, hydrogen peroxide, sample buffer, DTT, stacking matrix, separation matrix, running buffer, wash buffer, and matrix removal buffer, secondary antibodies, antibody diluent, and capillaries) were obtained from the manufacturer and used with minor modifications 13, 50 . The mouse monoclonal 5-HT 2C R 78 (D-12; sc-17797 Santa Cruz; 1:10), mouse monoclonal transferrin receptor (TfR, CD71; 136890 Invitrogen; 1:10,000), mouse monoclonal synaptophysin (p38, MAB329, 1:7500, Millipore) and rabbit monoclonal β-actin antibodies (8457, Cell Signaling Technology, 1:50) were diluted with ProteinSimple antibody diluent. Equal amounts of protein (2 µg for MAB329 or 4 µg for all other antibodies) were combined with 0.1X sample buffer and 5X master mix (200 mM DTT, 5X sample buffer, 5X fluorescent standards), gently mixed, and then denatured at 90 °C for 10 min. The denatured samples, biotinylated ladder, antibody diluent, primary antibodies, horseradish peroxidase (HRP) conjugated secondary antibodies, chemiluminescent substrate, and wash buffer were dispensed to designated wells in a pre-filled microplate. Separation electrophoresis (375 V, 28 min, 25 °C) and immunodetection in the capillaries were fully automated using the following settings: separation matrix load for 200 sec, stacking matrix load for 20 sec, sample load for 12 sec, antibody diluent for 30 min, primary antibody incubation for 60 min, secondary antibody incubation for 30 min, and chemiluminescent signal exposure for 5, 15, 30, 60, 120, 240, and 480 sec. Data analyses were performed using the Compass Software (ProteinSimple). Representative "virtual blot" electrophoretic images were automatically generated by the Compass Software (ProteinSimple). Each experiment was performed in technical triplicates with three to seven biological replicates.
Surface biotinylation and Immunoblotting. Cell surface biotinylation protocol was modified from the Baratta et al. 79 protocol for isolating plasma membrane 5-HT 2C R protein expression using the Pierce Cell Surface Protein Isolation Kit (Thermo Scientific, Waltham, MA, Cat # 89881). Five flasks of Cys23 or Ser23 5-HT 2C R stably transfected CHOp38 cells were grown to 70% confluency and were washed twice with cold PBS on ice. Contents of 1 vial Sulfo-NHS-SS-Biotin was dissolved in 48 mL ice cold PBS (ph7.4) to create the biotin solution. Biotin solution (2 mg/mL) was added to flasks and incubated for 1 hr at 4 °C on an orbital shaker. The reaction was quenched using the quenching solution at 500 µL/flask for 20 min on ice. The cells were scraped into the solution from each flask and placed into a 50 mL centrifuge tube. Flasks were then rinsed with a total of 10 mL of Tris Buffered Saline (TBS) and added to the 50 mL centrifuge tube. Cells were centrifuged at 500 g for 3 min at 4 °C and the supernatant was removed. These cells were then resuspended in 5 mL of ice cold TBS and centrifuged at 500 g for 3 min at 4 °C. The supernatant was removed and this step was repeated one additional time. The cellular pellet was stored at −80 °C.
On the day of the assay, each pellet was thawed on ice and 250 µL of homogenization buffer [50 mM Tris-Cl,150 mM NaCl, pH 8.0, protease inhibitor cocktail and phosphatase inhibitor 2 and 3 cocktails (10 µL/ mL)] with 0.25% NP40 was added to each pellet. The lysed cells were then centrifuged at 1,000 g for 20 min at 4 °C and the supernatant #1 was collected. The Homogenization buffer with 0.25% NP40 (250 µL) was then added to the cellular pellet and mixed vigorously via vortexing, motorized pestle and trituration then allowed to incubate for 30 min at 4 °C vortexing every 5 min. An aliquot of the solution (50 µL) was saved as a whole cell fraction (i.e. total fraction) and stored at −20 °C. Thus, the total fraction ( Supplementary Fig. 4) is taken from whole cell lysate pellet just after lysis. The remaining 200 µL was centrifuged at 1000 g for 2 min at 4 °C and the supernatant was collected and combined with supernatant #1 and stored at −80 °C. Protein concentrations were determined using the BCA protein assay kit.
To set up isolation of labeled proteins, 150 uL NutrAvidin agarose was added to new tubes and briefly centrifuged (1,000 g at 25 °C). The supernatant was discarded and the beads were washed 3x with Homogenization buffer by discarding the supernatant following a 1,000 g spin for 2 min at 25 °C. The supernatant was then thawed and 1 mg of protein was loaded onto the NutrAvidin agarose, sealed with parafilm and allowed to incubate on a carousel for 18 hr at 4 °C. The protein bound NutrAvidin agarose was then centrifuged at 1,000 g for 2 min at 4 °C and the supernatant was transferred to a new tube (non-surface fraction) and stored at −80 °C. The non-surface fraction is the flow through ( Supplementary Fig. 4) , it is all proteins not surface biotinylated, and thus, did not bind to the NutrAvidin agarose. The NutrAvidin agarose was next washed 3x with 200 µL Homogenization buffer at 1,000 g at 25 °C, discarding the supernatant each time. Protein was eluted from the NutrAvidin agarose by vortexing with 80 µL of SDS-PAGE sample buffer (Thermo Scientific, Waltham, MA, Cat # 39001) with 50 mM DTT added to each column. Each tube was sealed with parafilm and incubated at 25 °C on a carousel for 1 hr. The tubes were then centrifuged for 2 min at 1,000 g at 25 °C and the supernatant collected (surface fraction). The surface fraction ( Supplementary Fig. 4 ) contains all proteins that were surface biotinylated and eluted from the NutrAvidin agarose.
Analysis of 5-HT 2C R protein expression in the different fractions was preformed using Western blot analysis. In brief, 35 µg of non-surface fraction, 35 µg total fraction and 45 µL of the surface fraction were denatured at 95 °C for 10 min and loaded onto precast gels (NuPage ™ 4-12% Bis-Tris; Invitrogen, catalog # NP0335BOX), transferred to PVDF membranes, (Immun-Blot ® PVDF membranes; Bio-Rad, catalog # 162-0239) and immunoblotted with the goat polyclonal antibody towards the 5-HT 2C R 78 (N-19, sc-15081, Santa Cruz; 1: 250) overnight at 4 °C. Membranes were incubated with goat IgG IRDye 680 LT (926-68024, LI-COR, 1:10,000, 2 hr at 25 °C) for detection by Odyssey Imaging System (LI-COR, Lincoln, NE). The experiment was replicated in two biological replicates.
Immunocytochemistry. Immunocytochemistry was conducted using CHOp38 cells transiently transfected with the Cys23 allele or Ser23 allele grown in chamber slides, as described above. In short, 2 µg of the Cys23 allele or Ser23 allele zeocin-resistant pcDNA3.1 plasmids were transfected into CHOp38 cells using Fugene ® 6
Transfection Reagent (Promega Corporation) according to the manufacturer's specifications; the immunocytochemistry assay started 24 hr post transfection. Where needed GalNac-O-Bn was added six hrs post transfection at a 2 mM concentration. Cells were incubated with serum-replete media for one-two hrs with or without 2 mM GalNac-O-Bn. Cells used for the TfR and EEA1 colocalization studies were then treated for 60 min with serum free media or 1 µM 5-HT. All cells were then rapidly washed twice in ice-cold PBS and fixed in cold 4% paraformaldehyde (15 min). After fixation, cells were washed twice with PBS, permeabilized with 100 µM digitonin (10 min), and then washed twice with 0.1% PBS-Tween 20 (PBST). The plasma membrane marker wheat germ agglutinin (WGA, Alexa 594 conjugated, W11262, Invitrogen) was added at a concentration of 5 µg/mL in PBS for 10 min at 25 °C to the wells and then washed twice with PBS before digitonin permeabilization. Chamber wells were incubated with 4% normal donkey serum for 60 min to block nonspecific antibody binding, followed by primary antibodies to 5-HT 2C R (D12-488 directly conjugated to Alexa 488, 1:1000, Santa Cruz), early endosomal antigen (EEA1, AB2900, 1:3000, Abcam), GRASP65 (PA3-910, 1:1000, ThermoFisher) and TfR (ab84036,1:500, Abcam) in 4% normal donkey serum for two hrs at 25 °C and then overnight at 4 °C. The chambers were then removed leaving the gasket still attached to the slide and washed five times in 0.1% PBST. The slide was then incubated with anti-rabbit 594 in 4% normal donkey serum for 60 min at 25 °C. The slide was washed five times in 0.1% PBST, once in PBS and mounted using DAPI-containing mounting medium (Vectasheild, Vector Laboratories, H-1000).
Confocal microscopy. For each condition 20-30 fields of view containing on average one-four Cys23
allele-or Ser23 allele-expressing cells per field of view were acquired mid-cell and represented as a projection (Fig. 3A,B ) or as single cuts (Figs 4-6; Supplementary Fig. 3 ) 47, 48 with lasers 405, 488 and 561 nm using the Leica True Confocal Scanner SPE and Leica Application Suite Advanced software (Leica Microsystems, Wetzlar, Germany). Photomicrographs were taken with 63X oil immersion lens at a zoom of 1.5, 1024 × 1024-pixel size, a pinhole of 137.13 µm and a scanning speed of 400 Hz. Each experiment was performed on a minimum of three biological replicates with 40-70 cells analyzed for each condition per receptor variant.
Statistical analyses. The E max was defined in the ++ Ca i assay as the maximum possible Ca i ++ response and potency was determined using the pEC 50 . The E max and pEC 50 values were calculated using 4-parameter nonlinear regression analysis (GraphPad Prism Version 7.02). Data from saturation binding isotherms are presented as B MAX and K D values, as computed by GraphPad Prism using specific binding with Hill slope nonlinear regression curve-fitting algorithm. Emax, pEC50, B MAX , or K d values between the Cys23-CHOp38 and Ser23-CHO-p38 cell lines were analyzed with a Student's t-test (α = 0.05). The Western blot analysis signal is defined as the area under the curve for the 5-HT 2C R, synaptophysin/p38 and TfR electropherogram peaks and was normalized to the area under the curve of the β-actin electropherogram peak (ProteinSimple); analyses of protein expression levels between the Cys23 allele and the Ser23 allele were made with a Student's t-test (α = 0.05) Quantification of immunocytochemistry colocalization was preformed using the Pearson's correlation statistic on unsaturated images ( Supplementary Fig. 3 and 5 ). The Pearson's correlation statistic was calculated by the LAS X Life Science software by drawing a region of interest around each expressing cell and the level of yellow pixel intensity (i.e., colocalization) measured. Analyses between the average Pearson's correlation for 5-HT 2C R colocalization with WGA in the Cys23 allele-or Ser23 allele-expressing cells were made with a Students t-test (α = 0.05). Analyses between the average Pearson's correlation for 5-HT 2C R colocalization with GRASP65, TfR or EEA1 in the Cys23 allele-or Ser23 allele-expressing cells were made with a two-way ANOVA with subsequent a priori comparisons using Students t-test as appropriate 80, 81 (α = 0.05).
